VRCA
Verrica Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$6.91
+0.30 (+4.54%)
Open$6.70
Previous Close$6.61
Day High$7.07
Day Low$6.70
52W High$11.91
52W Low$5.30
Volume—
Avg Volume453.4K
Market Cap113.37M
P/E Ratio14.11
EPS$0.64
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+38.8% upside
Current
$6.91
$6.91
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 35.21M | 35.73M | 38.70M |
| Net Income | 7.35M | 6.74M | 10.01M |
| Profit Margin | 20.9% | 18.9% | 25.9% |
| EBITDA | 14.30M | 12.85M | 15.80M |
| Free Cash Flow | 5.70M | 8.80M | 7.67M |
| Rev Growth | +1.0% | +7.9% | +5.4% |
| Debt/Equity | 0.45 | 0.56 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |